Early changes by 18Fluorodeoxyglucose positron emission tomography coregistered with computed tomography predict outcome after Mycobacterium tuberculosis infection in cynomolgus macaques

Infection and Immunity

Volumn 82, Issue 6, 2014, Pages 2400-2404

  Coleman, M Teresa ^a   Maiello, Pauline ^a   Tomko, Jaime ^a   Frye, Lonnie James ^b   Fillmore, Daniel ^a   Janssen, Christopher ^b   Klein, Edwin ^b   Lin, Philana Ling ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADAPTIVE IMMUNITY; ADULT; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTROLLED STUDY; DIFFERENTIAL DIAGNOSIS; DISEASE COURSE; DISEASE DURATION; INNATE IMMUNITY; LATENT TUBERCULOSIS; LUNG GRANULOMA; MACACA FASCICULARIS; MEDIASTINUM LYMPH NODE; METABOLIC ACTIVATION; MONKEY DISEASE; NONHUMAN; PET SCANNER; PREDICTIVE VALUE; PRIORITY JOURNAL; TUBERCULOSIS; ANIMAL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC USE; MONKEY DISEASES; MYCOBACTERIUM TUBERCULOSIS; PATHOLOGY; POSITRON EMISSION TOMOGRAPHY; PROCEDURES;

ANIMALS; DISEASE PROGRESSION; FLUORODEOXYGLUCOSE F18; MACACA FASCICULARIS; MONKEY DISEASES; MYCOBACTERIUM TUBERCULOSIS; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TUBERCULOSIS;

EID: 84900426355     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01599-13     Document Type: Article

References (21)

1. World Health Organization. 2013. Global tuberculosis report. World Health Organization, Geneva, Switzerland.
2. Davis SL, Nuermberger EL, Um PK, Vidal C, Jedynak B, Pomper MG, Bishai WR, Jain SK. 2009. Noninvasive pulmonary [18F]-2-fluorodeoxy-D-glucose positron emission tomography correlates with bactericidal activity of tuberculosis drug treatment. Antimicrob. Agents Chemother. 53:4879-4884. http://dx.doi.org/10.1128/AAC.00789-09.
3. Via LE, Schimel D, Weiner DM, Dartois V, Dayao E, Cai Y, Yoon YS, Dreher MR, Kastenmayer RJ, Laymon CM, Carny JE, Flynn JL, Herscovitch P, Barry CE, III. 2012. Infection dynamics and response to chemotherapy in a rabbit model of tuberculosis using [(1)(8)F]2-fluorodeoxy-D-glucose positron emission tomography and computed tomography. Antimicrob. Agents Chemother. 56:4391-4402. http://dx.doi.org/10.1128/AAC.00531-12.
4. Lin PL, Coleman T, Carney JP, Lopresti BJ, Tomko J, Fillmore D, Dartois V, Scanga C, Frye LJ, Janssen C, Klein E, Barry CE, III, Flynn JL. 2013. Radiologic responses in cynomolgus macaques for assessing tuberculosis chemotherapy regimens. Antimicrob. Agents Chemother. 57:4237-4244. http://dx.doi.org/10.1128/AAC.00277-13.
5. Lin PL, Rodgers M, Smith L, Bigbee M, Myers A, Bigbee C, Chiosea I, Capuano SV, Fuhrman C, Klein E, Flynn JL. 2009. Quantitative comparison of active and latent tuberculosis in the cynomolgus macaque model. Infect. Immun. 77:4631-4642. http://dx.doi.org/10.1128/IAI.00592-09.
6. Capuano SV, III, Croix DA, Pawar S, Zinovik A, Myers A, Lin PL, Bissel S, Fuhrman C, Klein E, Flynn JL. 2003. Experimental Mycobacterium tuberculosis infection of cynomolgus macaques closely resembles the various manifestations of human M. tuberculosis infection. Infect. Immun. 71:5831-5844. http://dx.doi.org/10.1128/IAI.71.10.5831-5844.2003.
7. Barry CE, III, Boshoff HI, Dartois V, Dick T, Ehrt S, Flynn J, Schnappinger D, Wilkinson RJ, Young D. 2009. The spectrum of latent tuberculosis: rethinking the biology and intervention strategies. Nat. Rev. Microbiol. 7:845-855. http://dx.doi.org/10.1038/nrmicro2236.
8. Berry MP, Graham CM, McNab FW, Xu Z, Bloch SA, Oni T, Wilkinson KA, Banchereau R, Skinner J, Wilkinson RJ, Quinn C, Blankenship D, Dhawan R, Cush JJ, Mejias A, Ramilo O, Kon OM, Pascual V, Banchereau J, Chaussabel D, O'Garra A. 2010. An interferon-inducible neutrophil-driven blood transcriptional signature in human tuberculosis. Nature 466:973-977. http://dx.doi.org/10.1038/nature09247.
9. Lin PL, Flynn JL. 2010. Understanding latent tuberculosis: a moving target. J. Immunol. 185:15-22. http://dx.doi.org/10.4049/jimmunol.0903856.
10. Andreu J, Caceres J, Pallisa E, Martinez-Rodriguez M. 2004. Radiological manifestations of pulmonary tuberculosis. Eur. J. Radiol. 51:139-149. http://dx.doi.org/10.1016/j.ejrad.2004.03.009.
11. Lin PL, Dartois V, Johnston PJ, Janssen C, Via L, Goodwin MB, Klein E, Barry CE, III, Flynn JL. 2012. Metronidazole prevents reactivation of latent Mycobacterium tuberculosis infection in macaques. Proc. Natl. Acad. Sci. U. S. A. 109:14188-14193. http://dx.doi.org/10.1073/pnas.1121497109.
12. Lin PL, Myers A, Smith L, Bigbee C, Bigbee M, Fuhrman C, Grieser H, Chiosea I, Voitenek NN, Capuano SV, Klein E, Flynn JL. 2010. Tumor necrosis factor neutralization results in disseminated disease in acute and latent Mycobacterium tuberculosis infection with normal granuloma structure in a cynomolgus macaque model. Arthritis Rheum. 62:340-350. http://dx.doi.org/10.1002/art.27271.
13. Lin PL, Pawar S, Myers A, Pegu A, Fuhrman C, Reinhart TA, Capuano SV, Klein E, Flynn JL. 2006. Early events in Mycobacterium tuberculosis infection in cynomolgus macaques. Infect. Immun. 74:3790-3803. http://dx.doi.org/10.1128/IAI.00064-06.
14. Lin PL, Ford CB, Coleman MT, Myers A, Gawande R, Ioerger TR, Sacchettini JC, Fortune SM, Flynn JL. 2014. Sterilization of granulomas is common in both active and latent tuberculosis despite extensive withinhost variability in bacterial killing. Nat. Med. 20:75-79. http://dx.doi.org/10.1038/nm.3412.
15. Canetti G. 1955. The tubercle bacillus. Springer Publishing Co, Inc., New York, NY.
16. Ottenhoff TH, Kaufmann SH. 2012. Vaccines against tuberculosis: where are we and where do we need to go? PLoS Pathog. 8:e1002607. http://dx.doi.org/10.1371/journal.ppat.1002607.
17. Coffman RL, Sher A, Seder RA. 2010. Vaccine adjuvants: putting innate immunity to work. Immunity 33:492-503. http://dx.doi.org/10.1016/j.immuni.2010.10.002.
18. Zumla A, Raviglione M, Hafner R, von Reyn CF. 2013. Tuberculosis. N. Engl. J. Med. 368:745-755. http://dx.doi.org/10.1056/NEJMra1200894.
19. Arentz M, Hawn TR. 2007. Tuberculosis infection: insight from immunogenomics. Drug Discov. Today Dis. Mech. 4:231-236. http://dx.doi.org/10.1016/j.ddmec.2007.11.003.
20. Kleinnijenhuis J, Oosting M, Joosten LA, Netea MG, Van Crevel R. 2011. Innate immune recognition of Mycobacterium tuberculosis. Clin. Dev. Immunol. 2011:405310. http://dx.doi.org/10.1155/2011/405310.
21. Li Y, Wang Y, Liu X. 2012. The role of airway epithelial cells in response to mycobacteria infection. Clin. Dev. Immunol. 2012:791392. http://dx.doi.org/10.1155/2012/791392.